Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 12/20 | 0.47 |
| ▸ | AKT2 | P31751 | 9/20 | 0.47 |
| ▸ | CKS1B | P61024 | 2/20 | 0.37 |
| ▸ | SKP1 | P63208 | 2/20 | 0.37 |
| ▸ | SKP2 | Q13309 | 2/20 | 0.37 |
| ▸ | MAPK8 | P45983 | 4/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | TACR3 | P29371 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10279756 | 1.00 | AKT1 (0.47) | AKT1AKT2CKS1BSKP1SKP2 | |
| SCHEMBL10279754 | 0.97 | AKT1 (0.49) | AKT1AKT2CKS1BSKP1SKP2 | |
| SCHEMBL15116250 | 0.95 | AKT1 (0.48) | AKT1AKT2CKS1BSKP1SKP2 | |
| SCHEMBL10279755 | 0.88 | AKT1 (0.51) | AKT1AKT2CKS1BSKP1SKP2 | |
| SCHEMBL362189 | 0.87 | AKT1 (0.52) | AKT1AKT2CKS1BSKP1SKP2 | |
| SCHEMBL10279926 | 0.86 | AKT1 (0.47) | AKT1AKT2CKS1BSKP1SKP2 | |
| SCHEMBL10279771 | 0.85 | AKT1 (0.46) | AKT1AKT2CKS1BSKP1SKP2 | |
| SCHEMBL10279928 | 0.85 | AKT1 (0.49) | AKT1AKT2CKS1BSKP1SKP2 | |
| SCHEMBL361759 | 0.85 | AKT1 (0.53) | AKT1AKT2CKS1BSKP1SKP2 | |
| SCHEMBL15106808 | 0.85 | AKT1 (0.49) | AKT1AKT2CKS1BSKP1SKP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2593458-A1 | BICYCLIC PYRIMIDINES | Bayer Intellectual Property GmbH (DE) | 2013-05-22 | — | — | EP | disclosed |
| WO-2012007416-A1 | BICYCLIC PYRIMIDINES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-01-19 | — | — | WO | disclosed |